MedTrace Logo

LAMP Assay for the Diagnosis of Visceral Leishmaniasis

NCT04003532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-12-20

No results posted yet for this study

Summary

This study will evaluate the of the loop-mediated amplification assay (LAMP) as a diagnostic as well as a Test-of-Cure (ToC) for visceral leishmaniasis (VL) in an endemic area in Ethiopia. Furthermore, we aim to further development of the direct-blood PCR-Nucleic Acid Lateral-Flow Immuno-Assay (dB-PCR-NALFIA) as a novel diagnostic tool for VL and its subsequent evaluation in the field.

Conditions

  • Visceral Leishmaniasis

Sponsors & Collaborators

  • European and Developing Countries Clinical Trials Partnership (EDCTP)

    collaborator OTHER_GOV

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • Prof. Dawit Wolday

    lead OTHER

Principal Investigators

  • Amanuel Haile, MD · Mekelle University College of Health Sciences

Eligibility

Min Age
5 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2022-06-30
Completion
2023-06-30

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04003532 on ClinicalTrials.gov